最有看点的互联网金融门户

最有看点的互联网金融门户
互联网经济国际资讯

亚马逊成功收购在线药房PillPack

近日,电商巨头亚马逊宣布,已经顺利与在线药房PillPack达成收购交易。该消息进一步表明,在接下来几年中,亚马逊有着进一步巩固自己在医疗健康领域地位的计划和决心。而且,就在此前一周,它还宣布已经为旗下医疗健康企业(与伯克希尔·哈撒韦公司以及摩根大通集团合资成立)定好了合适的首席执行官人选。

虽然目前亚马逊并未披露交易细节,但知情人士表示,该笔交易价值几乎达到10亿美元。据此前的相关报道指出,PillPack还就收购交易与亚马逊有力竞争对手——零售巨头沃尔玛进行过协商谈判。随后经过求证,这一点也的确属实。只不过,后来又有另一家公司加入战局,并且提供了更为诱人的收购条件。照现在的情况来看,那就是加入进来的就是亚马逊。

根据PitchBook的数据显示,PillPack在2016年完成最新一轮融资之后,估值达到3.61亿美元。按照计划,此次收购交易将会在今年下半年正式完成。

亚马逊借助此举,向我们传递出一个信号,那就是电子健康市场已经越来越热。作为一家致力于深入消费者生活方方面面的公司,亚马逊也是将这一块看作自己的重要战略领域,希望能够成为消费者或者医疗机构出现医疗需求时的首要选择。

Jeff Wilke是亚马逊旗下全球消费者集团(Worldwide Consumer)的负责人,他在一次新闻发布会上表示:“PillPack的团队非常富有远见,不仅拥有医药行业的丰富工作经历,还非常关注先进科技的发展运用。这家公司以一种极其有意义的方式,提高了用户的生活质量。因此,我们希望能够为它提供力所能及的帮助,继续让消费者享受到更为方便和健康的生活,同时为他们在繁忙的工作生活中节约时间。总之,接下来,我们很期待亚马逊与PillPack之间能够擦出火花,更好地造福消费者。”

目前,PillPack已经拿到了在美国50个州内的经营许可。不过,它还没有进军国际市场的计划。作为直接触及消费者的平台,其操作系统PharmacyOS能够管理患者数据,在药品剂量安全性问题上做出合理判断。

此次收购交易完成后,PillPack联合创始人兼首席执行官TJ Parker仍将复杂具体的业务运营。自2013年成立以来,它已经顺利拿到了1.23亿美元的融资,投资方包括Accel、Charles River Ventures和Menlo Ventures等。

A week after appointing a CEO for its healthcare joint venture with Berkshire Hathaway and JPMorgan, Amazon  today announced an acquisition that underscores how it also hopes to have a more direct — and more commercial — role in the world of healthcare in the coming years. The company has purchased PillPack, an online pharmacy the lets users buy medications in pre-made doses.

Terms of the deal have not been disclosed by Amazon, but sources close to the deal say it was for just under $1 billion. PillPack  had reportedly been in talks with Walmart — one of Amazon’s big rivals — for an acquisition, and we confirmed that this was indeed the case. “But someone” — that is, Amazon — “came along offering more.”

According to PitchBook, PillPack was last valued at $361 million after a round of funding in 2016. This deal is expected to close in the second half of 2018.

The move (and that reported valuation hike) signal how heated the e-health market is becoming, and also how Amazon views it as a key frontier in its bid to be the go-to place for anything a consumer (or medical organization) might want or need in the area of healthcare.

The might of Amazon in commerce plays a massive role in how the market is poised to develop: it buying the company is not only a signal of how PillPack will likely get scaled out (not least through Amazon’s healthcare JV) but also because of how other pharmacy companies will have to respond. So far, the market is punishing the rest for not already being where Amazon appears to be going.

“PillPack’s visionary team has a combination of deep pharmacy experience and a focus on technology,” says Jeff Wilke, Amazon CEO of Worldwide Consumer, in a news release. “PillPack is meaningfully improving its customers’ lives, and we want to help them continue making it easy for people to save time, simplify their lives, and feel healthier. We’re excited to see what we can do together on behalf of customers over time.”

PillPack has a license to operate in all 50 states in the U.S. and has other accreditations such as URAC AND VIPPS, but it doesn’t seem to be operational in international markets. Its PharmacyOS — the system it has built that forms the basis of the company — is a platform that helps manage patient data and figure out how to balance meds together in safe doses for its customers.

The challenge that the company is addressing is very real: The US is a huge consumer of medicines, and some of that has tipped into a large epidemic of abuse. While there are a lot of things that will have to happen to tackle that in the long and short term, at least helping to provide controlled doses of what patients are being prescribed is one aspect of how to tackle the problem.

It looks like TJ Parker, co-founder and CEO of PillPack, will be staying on to run the business.

“PillPack makes it simple for any customer to take the right medication at the right time, and feel healthier,” he said in a statement. “Together with Amazon, we are eager to continue working with partners across the healthcare industry to help people throughout the U.S. who can benefit from a better pharmacy experience.”

PillPack, based in Manchester, New Hampshire, started out at Techstars in Boston in 2013, when it was still led by Katie Rae, and over the years it had raised $123 million with investors, including Accel, Accomplice, Charles River Ventures and Menlo Ventures.


用微信扫描可以分享至好友和朋友圈

扫描二维码或搜索微信号“iweiyangx”
关注未央网官方微信公众号,获取互联网金融领域前沿资讯。

发表评论

发表评论

您的评论提交后会进行审核,审核通过的留言会展示在下方留言区域,请耐心等待。

评论

您的个人信息不会被公开,请放心填写! 标记为的是必填项

取消

亚马逊向其印度支付子公司Amazon Pay投资23亿卢比

Press Trus... | 移动支付网 1小时前

微软公司呼吁对面部识别技术进行监管

高旭 2天前

硅谷巨头纷纷加码,“金矿”保险业会因科技介入被颠覆吗?

Martha Not... 2天前

亚马逊的金融科技版图

耿颖 07-03

挑战阿里?亚马逊借贷业务可能要落户中国了

Hugh Son &... 06-28

版权所有 © 清华大学五道口金融学院互联网金融实验室 | 京ICP备17044750号-1